The effect of treatment expectations on pruritus and skin pain von Krefting, F, Hölsken, S, Schedlowski, M, Sondermann, W

Volltext

Psoriasis, cardiovascular risk factors and metabolic disorders: sex‐specific findings of a population‐based study von Sondermann, W., Djeudeu Deudjui, D.A., Körber, A., Slomiany, U., Brinker, T.J., Erbel, R., Moebus, S.

Volltext

Differential influence of vemurafenib and dabrafenib on patients’ lymphocytes despite similar clinical efficacy in melanoma von Schilling, B., Sondermann, W., Zhao, F., Griewank, K.G., Livingstone, E., Sucker, A., Zelba, H., Weide, B., Trefzer, U., Wilhelm, T., Loquai, C., Berking, C., Hassel, J., Kähler, K.C., Utikal, J., Al Ghazal, P., Gutzmer, R., Goldinger, S.M., Zimmer, L., Paschen, A., Hillen, U., Schadendorf, D.

Volltext

Reply to the letters to the editor ‘Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma’ by Diwakar et al... von Schilling, B., Sondermann, W., Griewank, K.G., Livingstone, E., Zimmer, L., Hillen, U., Schadendorf, D.

Volltext

Common Fundamentals of Psoriasis and Depression von Hölsken, Stefanie, Krefting, Frederik, Schedlowski, Manfred, Sondermann, Wiebke

Volltext

Trial of Spesolimab for Generalized Pustular Psoriasis von Bachelez, Hervé, Choon, Siew-Eng, Marrakchi, Slaheddine, Burden, A. David, Tsai, Tsen-Fang, Morita, Akimichi, Navarini, Alexander A, Zheng, Min, Xu, Jinhua, Turki, Hamida, Anadkat, Milan J, Rajeswari, Sushmita, Hua, Hairui, Vulcu, Sebastian D, Hall, David, Tetzlaff, Kay, Thoma, Christian, Lebwohl, Mark G

Volltext

Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma von SCHILLING, B, SONDERMANN, W, LOQUAI, C, BERKING, C, HASSEL, J, KÄHLER, K. C, UTIKAL, J, AL GHAZAL, P, GUTZMER, R, GOLDINGER, S. M, ZIMMER, L, PASCHEN, A, ZHAO, F, HILLEN, U, SCHADENDORF, D, GRIEWANK, K. G, LIVINGSTONE, E, SUCKER, A, ZELBA, H, WEIDE, B, TREFZER, U, WILHELM, T

Volltext

379 Efficacy of spesolimab in patients with generalized pustular psoriasis (GPP) flares with and without systemic inflammation von Tsai, T., Imafuku, S., Sondermann, W., Viguier, M., Elewski, B., Li, L., Quaresma, M., Thoma, C., Choon, S.

Volltext

Expectation-induced enhancement of pain, itch and quality of life in psoriasis patients: study protocol of a randomised controlled trial von Hölsken, Stefanie, Krefting, Frederik, Schedlowski, Manfred, Sondermann, Wiebke

Volltext

Einfluss der Behandlungserwartung auf Pruritus und Hautschmerzen von Krefting, F., Hölsken, S., Schedlowski, M., Sondermann, W.

Volltext

How familiar are German dermatologists with placebo and nocebo effects and to what extend are these targeted in clinical practice - A survey within the dermatological community von Krefting, F, Hölsken, S, Benson, S, Schedlowski, M, Sondermann, W

Volltext

A brief screening tool for depression in psoriasis patients: The Two Questions Test in clinical practice von Hölsken, Stefanie, Krefting, Frederik, Schneider, Lea, Benson, Sven, Schedlowski, Manfred, Sondermann, Wiebke

Volltext

"I Was Almost in Disbelief" - Qualitative Analysis of Experiences and Expectations Among Psoriasis Patients Undergoing Biologic Treatment with Secukinumab von Hölsken, Stefanie, Benthin, Carina, Krefting, Frederik, Mühlhaus, Senta, Nestoriuc, Yvonne, Schedlowski, Manfred, Sondermann, Wiebke

Volltext

Psychosocial burden and body mass index are associated with dermatology-related quality of life in psoriasis patients von Sondermann, Wiebke, Schreiber, Anne, Körber, Andreas, Fiege, Oliver, Scherbaum, Norbert, Benson, Sven, Schedlowski, Manfred

Volltext

Einfluss der Behandlungserwartung auf Pruritus und Hautschmerzen von Krefting, F., Hölsken, S., Schedlowski, M., Sondermann, W.

Volltext

Klinische Bedeutung von Bakterien beim chronischen Ulcus cruris von Sondermann, W., Dissemond, J.

Volltext

Differential influence of vemurafenib and dabrafenib on patients’ lymphocytes despite similar clinical efficacy in melanoma von Schilling, B, Sondermann, W, Zhao, F, Griewank, K G, Livingstone, E, Sucker, A, Zelba, H, Weide, B, Trefzer, U, Wilhelm, T, Loquai, C, Berking, C, Hassel, J, Kähler, K C, Utikal, J, Al Ghazal, P, Gutzmer, R, Goldinger, S M, Zimmer, L, Paschen, A, Hillen, U, Schadendorf, D, Dermatologic Cooperative Oncology Group

Volltext

Reply to the letters to the editor 'Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma' by Diwakar et al von Schilling, B, Sondermann, W, Griewank, K G, Livingstone, E, Zimmer, L, Hillen, U, Schadendorf, D

Volltext

Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma von Schilling, B, Sondermann, W, Zhao, F, Griewank, K G, Livingstone, E, Sucker, A, Zelba, H, Weide, B, Trefzer, U, Wilhelm, T, Loquai, C, Berking, C, Hassel, J, Kähler, K C, Utikal, J, Al Ghazal, P, Gutzmer, R, Goldinger, S M, Zimmer, L, Paschen, A, Hillen, U, Schadendorf, D

Volltext

Legal aspects of natural attenuation in Germany von Sondermann, Dr Wolf Dieter, Knorpp, Birgit

Volltext